Pfizer Limited (NSE:PFIZER)

Pfizer Statistics

Total Valuation

Pfizer has a market cap or net worth of INR 228.76 billion. The enterprise value is 202.62 billion.

Market Cap	228.76B
Enterprise Value	202.62B

Important Dates

The last earnings date was Wednesday, November 12, 2025.

Earnings Date	Nov 12, 2025
Ex-Dividend Date	Jul 9, 2025

Share Statistics

Pfizer has 45.75 million shares outstanding. The number of shares has decreased by -0.01% in one year.

Current Share Class	45.75M
Shares Outstanding	45.75M
Shares Change (YoY)	-0.01%
Shares Change (QoQ)	-0.02%
Owned by Insiders (%)	0.01%
Owned by Institutions (%)	17.43%
Float	15.12M

Valuation Ratios

The trailing PE ratio is 27.25 and the forward PE ratio is 29.14.

PE Ratio	27.25
Forward PE	29.14
PS Ratio	9.63
PB Ratio	5.94
P/TBV Ratio	6.93
P/FCF Ratio	25.99
P/OCF Ratio	25.14
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 24.92, with an EV/FCF ratio of 23.02.

EV / Earnings	24.14
EV / Sales	8.53
EV / EBITDA	24.92
EV / EBIT	26.83
EV / FCF	23.02

Financial Position

The company has a current ratio of 5.38, with a Debt / Equity ratio of 0.02.

Current Ratio	5.38
Quick Ratio	4.57
Debt / Equity	0.02
Debt / EBITDA	0.11
Debt / FCF	0.10
Interest Coverage	78.84

Financial Efficiency

Return on equity (ROE) is 22.09% and return on invested capital (ROIC) is 12.16%.

Return on Equity (ROE)	22.09%
Return on Assets (ROA)	10.42%
Return on Invested Capital (ROIC)	12.16%
Return on Capital Employed (ROCE)	19.07%
Revenue Per Employee	14.86M
Profits Per Employee	5.25M
Employee Count	1,598
Asset Turnover	0.52
Inventory Turnover	1.77

Taxes

In the past 12 months, Pfizer has paid 2.74 billion in taxes.

Income Tax	2.74B
Effective Tax Rate	24.60%

Stock Price Statistics

The stock price has decreased by -3.44% in the last 52 weeks. The beta is 0.11, so Pfizer's price volatility has been lower than the market average.

Beta (5Y)	0.11
52-Week Price Change	-3.44%
50-Day Moving Average	5,166.94
200-Day Moving Average	4,925.81
Relative Strength Index (RSI)	38.91
Average Volume (20 Days)	19,254

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Pfizer had revenue of INR 23.75 billion and earned 8.39 billion in profits. Earnings per share was 183.47.

Revenue	23.75B
Gross Profit	15.32B
Operating Income	7.55B
Pretax Income	11.13B
Net Income	8.39B
EBITDA	7.78B
EBIT	7.55B
Earnings Per Share (EPS)	183.47

Balance Sheet

The company has 27.04 billion in cash and 898.30 million in debt, giving a net cash position of 26.14 billion or 571.39 per share.

Cash & Cash Equivalents	27.04B
Total Debt	898.30M
Net Cash	26.14B
Net Cash Per Share	571.39
Equity (Book Value)	38.48B
Book Value Per Share	841.24
Working Capital	28.31B

Cash Flow

In the last 12 months, operating cash flow was 9.10 billion and capital expenditures -294.30 million, giving a free cash flow of 8.80 billion.

Operating Cash Flow	9.10B
Capital Expenditures	-294.30M
Free Cash Flow	8.80B
FCF Per Share	192.44

Margins

Gross margin is 64.49%, with operating and profit margins of 31.80% and 35.34%.

Gross Margin	64.49%
Operating Margin	31.80%
Pretax Margin	46.86%
Profit Margin	35.34%
EBITDA Margin	32.77%
EBIT Margin	31.80%
FCF Margin	37.06%

Dividends & Yields

This stock pays an annual dividend of 35.00, which amounts to a dividend yield of 0.70%.

Dividend Per Share	35.00
Dividend Yield	0.70%
Dividend Growth (YoY)	371.43%
Years of Dividend Growth	n/a
Payout Ratio	89.66%
Buyback Yield	0.01%
Shareholder Yield	0.71%
Earnings Yield	3.67%
FCF Yield	3.85%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	5